GlassScriptPhysician profile
Jennifer L Nickol
NPI 1932620895
$20,761.89
in general payments reported to CMS, 2019-2025
15 companies · $18K in 2025
The $18K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $86.05 · 2020: $126 · 2021: $370 · 2022: $969 · 2023: $816 · 2024: $295 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $18K · Food and Beverage: $698 · Travel and Lodging: $412 · Education: $101.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $18,000.00 |
| Food and Beverage | $698.42 |
| Travel and Lodging | $411.67 |
| Education | $101.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $19,973.57 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Ensite |
| Novo Nordisk INC | $128.14 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $124.94 | 2022 | |
| Cardiva Medical, INC. | $122.18 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $110.60 | 2022-2024 | Lifevest |
| Astellas Pharma US INC | $99.00 | 2022 | |
| Abiomed | $56.78 | 2024-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $30.20 | 2025 | |
| Pfizer INC. | $29.24 | 2019-2024 | |
| Global Blood Therapeutics, INC. | $18.21 | 2020 | |
| Mylan Specialty L.P. | $16.89 | 2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.93 | 2025 | |
| Allergan, INC. | $12.64 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.55 | 2020 | |
| Amgen INC. | $12.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Nickol listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.